| Bafna Pharmaceuticals Ltd |
|---|
| Registered Office: Bafna Towers New No 68,Old No 299 Thambu Chetty St,Chennai-600001, Tamil Nadu |
| Tel. No: 91-44-25267517/25270992/4267755 |
| Fax No: 91-44-25231264/42677599 |
| Email: cs@bafnapharma.com; info@bafnapharma.com |
| Website: www.bafnapharma.com |
| Public Issue of 64,00,000 equity shares of Rs.10/- each at a price of Rs.40/- per equity share (including share premium of Rs.30/-per equity share) for cash aggregating Rs.25.60 Crores by Bafna Pharmaceuticals Limited (Hereinafter Referred to as the "Issue"). The issue will constitute 40.05% of the post issue paid-up capital of the company. The issue price is 4 times of the face value |
| Issue | Money Payable On | ||
|---|---|---|---|
| Opens On | Closes On | Application | Allotment |
| 27-May-2008 | 30-May-2008 | ₹40.00 - 0.00 | ₹0.00 - 0.00 |
| Minimum Application for shares in Nos : 150 | Further Multiples of :150 |
|---|
| (₹ Cr) | Lead Managers to the Issue | |
|---|---|---|
| Project Cost | 25.60 | Ashika Capital Ltd |
| Project Financed through Current Offer | 25.60 | Keynote Corporate Services Ltd |
| Post Issue Equity Share Capital | 15.98 | |
| Issue Price | 40.00 |
| Projects |
|---|
| To undertake Brand Buld in Domestic & Intl.Markets |
| To part Fin the cost of obtaining MHRA Approval |
| To Set up a Research & Development Unit |
| Tp Repay of High Cost Debt |
| To Meet the Working Capital Requirement |
| Promoted By |
|---|
| Bafna Mahaveer Chand |
| Paras Bafna |
| Navin Bafna |
| Listing At |
|---|
| BSE |
| Registrar To The Issue |
|---|